Reference Title EndPoint Method
Reference Title EndPoint Method
BIOCH-0013Acellular, Phosphodiesterase 1 inhibition (purified enzyme)*** (must be login)*** (must be login)
BIOCH-0025Acellular, TBARS formation*** (must be login)*** (must be login)
BIOCH-0021Acellular, Type IV collagenase inhibition (bacterial enzyme)*** (must be login)*** (must be login)
BIOCH-0010Acellular, Tyrosinase inhibition (mushroom enzyme)*** (must be login)*** (must be login)
BIOCH-0011Acellular, Tyrosinase inhibition (NHEM extract)Tyrosinase activityPhotometry
MONO-0014Activated M2 macrophages, Switch towards M1 macrophages (basal)CD80 and CD163 phenotyping and cell viability
TNF- alpha, IL-6, IL-12p70 release
Flow cytometry
NHA-0003Adipocytes, cAMP content (basal)*** (must be login)*** (must be login)
NHA-0004Adipocytes, lipid neosynthesis (basal)Lipid neosynthesis[14C]-acetate incorporation
NHA-0001Adipocytes, NEFA release (basal)Non-esterified fatty acid releasePhotometry
AOSMC-0001AoSMC, veinotonic activity (basal)Calcium mobilizationTime-lapse microscopy
ASTRO-0001Astrocytes, chemokine production (cytokine stimulation)CCL5 releaseELISA / EIA
B16-0002B16, inhibition of melanin synthesis (MSH-induced, whitening agents)*** (must be login)*** (must be login)
B16-0016B16, pigmentation-related gene expression (basal)*** (must be login)*** (must be login)
B16-0018B16, pigmentation-related gene expression (MSH stimulation)*** (must be login)*** (must be login)
B16-0001B16, stimulation of melanin synthesis (basal, pro-pigmenting agents)*** (must be login)*** (must be login)